Lipid nanoparticles: state of the art, new preparation methods and challenges in drug delivery

Bibliography

• Muller RH, Mader K, Gohla S. Solid lipid nanoparticles (SLN) for controlled drug delivery – a review of the state of the art. Eur J Pharm Biopharm 2000;50:161-77
   PubMed Web of Science ®Google Scholar
• Anton N, Benoit JP, Saulnier P. Design and production of nanoparticles formulated from nano-emulsion templates—a review. J Control Release 2008;128:185-99
   PubMed Web of Science ®Google Scholar
• Corrias F, Lai F. New methods for lipid nanoparticles preparation. Recent Pat Drug Deliv Formul 2011;5:201-13
   PubMedGoogle Scholar
• Carlotti ME, Sapino S, Trotta M, Photostability and stability over time of retinyl palmitate in an o/w emulsion and in SLN introduced in the emulsion. J Disper Sci Technol 2005;26:125-38
   Web of Science ®Google Scholar
• Hou D, Xie C, Huang K, The production and characteristics of solid lipid nanoparticles (SLNs). Biomaterials 2003;24:1781-5
   PubMed Web of Science ®Google Scholar
• Muller RH, Radtke M, Wissing SA. Nanostructured lipid matrices for improved microencapsulation of drugs. Int J Pharm 2002;242:121-8
   PubMed Web of Science ®Google Scholar
• Olbrich C, Mueller RH, Kayser O. Lipid drug conjugate nanoparticles as novel carrier system for the hydrophilic antitrypanosomal drug diminazene aceturate. J Drug Target 2002;10:387-96
   PubMed Web of Science ®Google Scholar
• Huynh NT, Passirani C, Saulnier P, Lipid nanocapsules: a new platform for nanomedicine Int J Pharm. 2009;379:201-9
   Google Scholar
• Shinoda K, Saito H. The stability of O/W type emulsions as a function of temperature and the HLB of emulsifiers: the emulsification by PIT-method. J Colloid Interface Sci 1969;30:258-63
   Web of Science ®Google Scholar
• Gasco MR. Method for producing solid lipid microspheres having a narrow size distribution. US5250236; 1993
   Google Scholar
• Koziara JM, Oh JJ, Akers WS, Blood compatibility of cetyl alcohol/polysorbate-based nanoparticles. Pharm Res 2005;22:1821-8
   PubMed Web of Science ®Google Scholar
• Schubert MA, Mueller-Goymann CC. Solvent injection as a new approach for manufacturing lipid nanoparticles – evaluation of the method and process parameters. Eur J Pharm Biopharm 2003;55:125-31
   PubMed Web of Science ®Google Scholar
• Hu FQ, Yuan H, Zhang H, Preparation of solid lipid nanoparticles with clobetasol propionate by a novel solvent diffusion method in aqueous system and physicochemical characterization. Int J Pharm 2002;239:121-8
   PubMed Web of Science ®Google Scholar
• Siekmann B, Westesen K. Investigation on solid lipid nanoparticles prepared by precipitation in o/w emulsion. Eur J Pharm Biopharm 1996;43:104-9
   Google Scholar
• Garcia-Fuentes M, Torres D, Alonso MJ. Design of lipid nanoparticles for the oral delivery of hydrophilic macromolecules. Colloids Surf B Biointerf 2002;27:159-68
   Web of Science ®Google Scholar
• Trotta M, Debernardi F, Caputo O. Preparation of solid lipid nanoparticles by a solvent emulsification-diffusion technique. Int J Pharm 2003;257:153-60
   PubMed Web of Science ®Google Scholar
• Gallarate M, Trotta M, Battaglia L, Preparation of solid lipid nanoparticles from W/O/W emulsions: preliminary studies on insulin encapsulation. J Microencapsul 2009;26:394-402
   PubMed Web of Science ®Google Scholar
• Battaglia L, Gallarate M, Cavalli R, Solid lipid nanoparticles produced through a coacervation method. J Microencapsul 2010;27:78-85
   PubMed Web of Science ®Google Scholar
• Chattopadhyay P, Shekunov BY, Yim D, Production of solid lipid nanoparticle suspensions using supercritical fluid extraction of emulsions (SFEE) for pulmonary delivery using the AERx system. Adv Drug Deliv Rev 2007;6:444-53
   Google Scholar
• Salmaso S, Elvassore N, Bertucco A, Production of solid lipid submicron particles for protein delivery using a novel supercritical gas-assisted melting atomization process. J Pharm Sci 2009;98:640-9
   PubMed Web of Science ®Google Scholar
• Charcosset C, El-Harati AA, Fessi H. Preparation of solid lipid nanoparticles using a membrane contactor. J Control Release 2005;108:112-20
   PubMed Web of Science ®Google Scholar
• Berton A, Piel G, Evrard B. Powdered lipid nano and microparticles: production and applications. Recent Pat Drug Deliv Formul 2011;5:188-200
   PubMedGoogle Scholar
• Jaspart S, Piel G, Delattre L, Solid lipid microparticles: formulation, preparation, characterisation, drug release and applications. Expert Opin Drug Deliv 2005;2:75-87
   PubMedGoogle Scholar
• Sebti T, Amighi K. Preparation and in vitro evaluation of lipidic carriers and fillers for inhalation. Eur J Pharm Biopharm 2006;63:51-8
   PubMed Web of Science ®Google Scholar
• Del Curto MD, Chicco D, D'Antonio M, Lipid microparticles as sustained release system for a GnRH antagonist (Antide). J Control Release 2003;89:297-310
   PubMed Web of Science ®Google Scholar
• Passerini N, Perissuti B, Albertini B, Controlled release of verapamil hydrochloride from waxy microparticles prepared by spray congealing. J Control Release 2003;88:263-75
   PubMed Web of Science ®Google Scholar
• Trotta M, Cavalli R, Trotta C, Electrospray technique for solid lipid-based particle production. Drug Dev Ind Pharm 2010;36:431-8
   PubMed Web of Science ®Google Scholar
• Battaglia L, Trotta M, Gallarate M, Solid lipid nanoparticles formed by solvent-in-water emulsion–diffusion technique: development and influence on insulin stability. J Microencapsul 2007;24:672-84
   Web of Science ®Google Scholar
• Gallarate M, Trotta M, Battaglia L, Cisplatin-loaded SLN produced by coacervation technique. J Drug Deliv Sci Tech 2010;20:343-7
   Web of Science ®Google Scholar
• Attama AA. SLN, NLC, LDC: state of the art in drug and active delivery. Recent Pat Drug Deliv Formul 2011;5:178-87
   PubMedGoogle Scholar
• Morel S, Terreno E, Ugazio E, NMR Relaxometric investigations of solid lipid nanoparticles (SLN) containing gadolinium (III) complexes. Eur J Pharm Biopharm 1998;45:157-63
   PubMed Web of Science ®Google Scholar
• Gallarate M, Battaglia L, Peira E, Peptide-loaded solid lipid nanoparticles prepared through coacervation technique. Int J Chem Eng 2011; doi:10.1155/2011/132435.
   Google Scholar
• Battaglia L, Serpe L, Muntoni E, Methotrexate loaded SLN prepared by coacervation technique: in vitro cytotoxicity and in vivo pharmacokinetic and biodistribution. Nanomedicine (Lond) 2011;6:1561-73
   PubMed Web of Science ®Google Scholar
• Brioschi A, Zara GP, Calderoni S, Cholesterylbutyrate solid lipid nanoparticles as a butyric acid prodrug. Molecules 2008;13:230-54
   PubMed Web of Science ®Google Scholar
• Wong HL, Bendayan R, Rauth AM, Development of solid lipid nanoparticles containing ionically-complexed chemotherapeutic drugs and chemosensitizers. J Pharm Sci 2004;93:1993-2004
   PubMed Web of Science ®Google Scholar
• Wong HL, Rauth AM, Bendayan R, A new polymer-lipid hybrid nanoparticle system increases cytotoxicity of doxorubicin against multidrug resistant human breast cancer cells. Pharm Res 2006;23:1574-85
   PubMed Web of Science ®Google Scholar
• Wong HL, Bendayan R, Rauth AM, A mechanistic study of enhanced doxorubicin uptake and retention in multidrug resistant breast cancer cells using a polymer-lipid hybrid nanoparticle (PLN) system. J Pharmacol Exp Ther 2006;317:1372-81
   PubMed Web of Science ®Google Scholar
• Li Y, Taulier N, Rauth AM, Screening of lipid carriers and characterization of drug-polymer complex for the rational design of polymer-lipid hybrid nanoparticles. Pharm Res 2006;23:1877-87
   PubMed Web of Science ®Google Scholar
• Bussano R, Chirio D, Costa L, Preparation and characterization of insulin loaded lipid-based microspheres generated by electrospray. J Disper Sci Technol 2011;32:1524-30
   Web of Science ®Google Scholar
• Siekmann B, Westesen K. Thermoanalysis of the recrystallization process of melt-homogenised glyceride nanoparticles. Colloid Surf B 1994;3:159-75
   Google Scholar
• Hunter RJ. Foundation of Colloidal Science. Oxford University Press; Oxford: 1986
   Google Scholar
• Hou D, Xie C, Huang K, The production and characteristics of solid lipid nanoparticles (SLN). Biomaterials 2003;24:1781-5
   PubMed Web of Science ®Google Scholar
• Liu J, Gong T, Wang C, Solid lipid nanoparticles loaded with insulin by sodium cholate-phosphatidylcholine-based mixed micelles. Preparation and characterisation. Int J Pharm 2007;340:153-62
   PubMed Web of Science ®Google Scholar
• Blumer C, Mader K. Isostatic ultra-high-pressure effects on supercooled melts in colloidal triglyceride dispersions. Pharm Res 2005;22:1708-15
   PubMed Web of Science ®Google Scholar
• Eldem T, Speiser P, Altorfer H. Polymorphic behavior of sprayed lipid micropellets and its evaluation by differential scanning calorimetry and scanning electron microscopy. Pharm Res 1991;8:178-84
   PubMed Web of Science ®Google Scholar
• Westesen K, Bunjes H. Do nanoparticles prepared from lipids solid at room temperature always possess a solid lipid matrix. Int J Pharm 1995;115:129-31
   Web of Science ®Google Scholar
• Sato K, Garti N. Crystallization and Polymorphism of Fats and Fatty Acids. Marcel Dekker; New York: 1988
   Google Scholar
• Mehnert W, Mader K. Solid lipid nanoparticles. Production, characterization and applications. Adv Drug Deliv Rev 2001;47:165-96
   PubMed Web of Science ®Google Scholar
• Heurtault B, Saulnier P, Pech B, Physico-chemical stability of colloidal lipid particles. Biomaterials 2003;24:4283-300
   PubMed Web of Science ®Google Scholar
• Freitas C, Muller RH. Spray-drying of solid lipid nanoparticles (SLN™). Eur J Pharm Biopharm 1998;46:145-51
   PubMed Web of Science ®Google Scholar
• Zimmermann E, Muller RH, Mader K. Influence of different parameters on reconstitution of lyophilised SLN. Int J Pharm 2000;196:211-13
   PubMed Web of Science ®Google Scholar
• Zimmermann E, Muller RH. Electrolytes- and pH-stability of aqueous solid lipid nanoparticles (SLN™) dispersion in artificial gastrointestinal media. Eur J Pharm Biopharm 2001;52:203-10
   PubMed Web of Science ®Google Scholar
• Olbrich C, Muller RH. Enzymatic degradation of SLN – effect of surfactant and surfactant mixtures. Int J Pharm. 1999;180:31-9
   Google Scholar
• Wissing SA, Kayser O, Muller RH. Solid lipid nanoparticles for parenteral drug delivery. Adv Drug Deliv Rev 2004;56:1257-72
   PubMed Web of Science ®Google Scholar
• Uner M, Yener G. Importance of solid lipid nanoparticles (SLN) in various administration routes and future perspectives. Int J Nanomed 2007;2:289-300
   PubMed Web of Science ®Google Scholar
• Muller RH, Radtke M, Wissing SA. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. Adv Drug Deliv Rev 2002;54:S131-55
   PubMed Web of Science ®Google Scholar
• Harde H, Das M, Jain S. Solid lipid nanoparticles: an oral bioavailability enhancer vehicle. Expert Opin Drug Deliv 2011;8:1407-24
   PubMed Web of Science ®Google Scholar
• Fricker G, Wendel A, Blume A, Phospholipids and lipid-based formulations in oral drug delivery. Pharm Res 2010;27:1469-86
   PubMed Web of Science ®Google Scholar
• Liu J, Gong T, Fu H, Solid lipid nanoparticles for pulmonary delivery of insulin. Int J Pharm 2008;356:333-44
   PubMed Web of Science ®Google Scholar
• Videira MA, Botelho MF, Santos AC, Lymphatic uptake of pulmonary delivered radiolabelled solid lipid nanoparticles. J Drug Target 2002;8:607-13
   Google Scholar
• Sanna V, Kirschvink N, Gustin P, Preparation and in vivo toxicity study of solid lipid microparticles as carrier for pulmonary administration. AAPS PharmSciTech 2004;5:e27
   PubMedGoogle Scholar
• Attama AA, Reichl S, Muller-Goymann CC. Diclofenac sodium delivery to the eye: in vitro evaluation of novel solid lipid nanoparticle formulation using human cornea construct. Int J Pharm 2008;355:307-13
   PubMed Web of Science ®Google Scholar
• Attama AA, Weber C, Muller-Goymann CC. Assessment of drug permeation from SLN formulated with a novel structured lipid matrix through artificial skin construct bio-engineered from HDF and HaCaT cell lines. J Drug Deliv Sci Technol 2008;18:181-8
   Web of Science ®Google Scholar
• Attama AA, Reichl S, Muller-Goymann CC. Sustained release and permeation of timolol from surface modified solid lipid nanoparticles through bio-engineered human cornea. Curr Eye Res 2009;34:698-705
   PubMed Web of Science ®Google Scholar
• Sandri G, Bonferoni MC, Gokce EH, Chitosan-associated SLN: in vitro and ex vivo characterization of cyclosporine A loaded ophthalmic systems. J Microencapsul 2010;27:735-46
   PubMed Web of Science ®Google Scholar
• Basaran E, Demirel M, Sirmagul B, Cyclosporine-A incorporated cationic solid lipid nanoparticles for ocular delivery. J Microencapsul 2010;27:37-47
   PubMed Web of Science ®Google Scholar
• Battaglia L, D'Addino I, Peira E, Solid lipid nanoparticles prepared by coacervation method as vehicles for ocular cyclosporine. J Drug Deliv Sci Technol 2012 in press
   Web of Science ®Google Scholar
• Sznitowska M, Gajewska M, Janicki S, Bioavailability of diazepam from aqueous-organic solution, submicron emulsion and solid lipid nanoparticles after rectal administration in rabbits. Eur J Pharm Biopharm 2001;52:159-63
   PubMed Web of Science ®Google Scholar
• Sznitowska M, Janicki S, Gajewska M, Investigation of diazepam lipospheres based on witepsol and lecithin intended for oral or rectal delivery. Acta Pol Pharm Drug Res 2000;57:61-4
   PubMedGoogle Scholar
• Wong HL, Bendayan R, Rauth AM, Chemotherapy with anticancer drugs encapsulated in solid lipid nanoparticles. Adv Drug Deliv Rev 2007;59:491-504
   PubMed Web of Science ®Google Scholar
• Moghimi SM, Hunter AC, Murray JC. Long-circulating and target-specific nanoparticles: theory to practice. Pharmacol Rev 2001;53:283-318
   PubMed Web of Science ®Google Scholar
• Beduneau A, Saulnier P, Anton N, Pegylated nanocapsules produced by an organic solvent-free method: evaluation of their stealth properties. Pharm Res 2006;23:2190-9
   PubMed Web of Science ®Google Scholar
• Du B, Yan Y, Li Y, Preparation and passive target of 5-fluorouracil solid lipid nanoparticles. Pharm Dev Technol 2010;15:346-53
   PubMed Web of Science ®Google Scholar
• Khalid MN, Simard P, Hoarau D, Long circulating poly(ethylene glycol)-decorated lipid nanocapsules deliver docetaxel to solid tumors. Pharm Res 2006;23:752-8
   PubMed Web of Science ®Google Scholar
• Hoarau D, Delmas P, David S, Novel long-circulating lipid nanocapsules. Pharm Res 2004;21:1783-9
   PubMed Web of Science ®Google Scholar
• Oyewumi MO, Mumper RJ. Influence of formulation parameters on gadolinium entrapment and tumor cell uptake using folate-coated nanoparticles. Int J Pharm 2003;251:85-97
   PubMed Web of Science ®Google Scholar
• Mulik RS, Monkkonen J, Juvonen RO. Transferrin mediated solid lipid nanoparticles containing curcumin: Enhanced in vitro anticancer activity by induction of apoptosis. Int J Pharm 2010;398:190-203
   PubMed Web of Science ®Google Scholar
• Jain A, Agarwal A, Majumder S, Mannosylated solid lipid nanoparticles as vectors for site-specific delivery of an anti-cancer drug. J Control Release 2010;148:359-67
   PubMed Web of Science ®Google Scholar
• Xu Z, Chen L, Gu W, The performance of docetaxel-loaded solid lipid nanoparticles targeted to hepatocellular carcinoma. Biomaterials 2009;30:226-32
   PubMed Web of Science ®Google Scholar
• Ma P, Dong X, Swadley CL, Development of idarubicin and doxorubicin solid lipid nanoparticles to overcome Pgp–mediated multiple drug resistance in leukemia. J Biomed Nanotechnol 2009;5:151-61
   PubMed Web of Science ®Google Scholar
• Dong X, Mattingly CA, Tseng MT, Doxorubicin and paclitaxel-loaded lipid-based nanoparticles overcome multidrug resistance by inhibiting P-glycoprotein and depleting ATP. Cancer Res 2009;69:3918-26
   PubMed Web of Science ®Google Scholar
• Garcion E, Lamprecht A, Heurtault B, A new generation of anticancer, drug-loaded, colloidal vectors reverses multidrug resistance in glioma and reduces tumor progression in rats. Mol Cancer Ther 2006;5:1710-22
   PubMed Web of Science ®Google Scholar
• Lamprecht A, Benoit JP. Etoposide nanocarriers suppress glioma cell growth by intracellular drug delivery and simultaneous P-glycoprotein inhibition. J Control Release 2006;112:208-13
   PubMed Web of Science ®Google Scholar
• Barbu E, Molnar E, Tsibouklis J, The potential for nanoparticle-based drug delivery to the brain: overcoming the blood–brain barrier. Expert Opin Drug Deliv 2009;6:553-65
   PubMed Web of Science ®Google Scholar
• Koziara JM, Lockman PR, Allen DD, Paclitaxel nanoparticles for the potential treatment of brain tumors. J Control Release 2004;99:259-69
   PubMed Web of Science ®Google Scholar
• Beduneau A, Saulnier P, Hindre F, Design of targeted lipid nanocapsules by conjugation of whole antibodies and antibody Fab' Fragments. Biomaterials 2007;28:4978-90
   PubMed Web of Science ®Google Scholar
• Beduneau A, Hindre F, Clavreul A, Brain targeting using novel lipid nanovectors. J Control Release 2008;126:44-9
   PubMed Web of Science ®Google Scholar
• Goppert TM, Muller RH. Polysorbate-stabilized solid lipid nanoparticles as colloidal carriers for intravenous targeting of drugs to the brain: comparison of plasma protein adsorption patterns. J Drug Target 2005;13:179-87
   PubMed Web of Science ®Google Scholar
• Del Pozo Rodriguez A, Delgado D, Solinis MA, Lipid nanoparticles as vehicles for macromolecules: nucleic acids and peptides. Recent Pat Drug Deliv Formul 2011;5:214-26
   PubMedGoogle Scholar
• Almeida AJ, Souto E. Solid lipid nanoparticles as a drug delivery system for peptides and proteins. Adv Drug Deliv Rev 2007;59:478-90
   PubMed Web of Science ®Google Scholar
• Elsabahy M, Nazarali A, Foldvari M. Non-viral nucleic acid delivery: key challenges and future directions. Curr Drug Deliv 2011;8:235-44
   PubMed Web of Science ®Google Scholar
• Bondı` ML, Craparo EF. Solid lipid nanoparticles for applications in gene therapy: a review of the state of the art. Expert Opin Drug Deliv 2010;7:7-18
   PubMed Web of Science ®Google Scholar
• Muller RH, Lucks JS. Arzneistofftrager aus festen lipidteilchen–feste lipid nanospharen (SLN). EP0605497; 1996
   Google Scholar
• Amighi K, Sebti T. Solid lipid particles as pharmaceutically acceptable fillers or carriers for inhalation. WO2006066367; 2006
   Google Scholar
• Rodriguez LC, Cavallari C, Motta G. Apparatus and method for preparing solid forms with controlled release of the active ingredient. WO9603979; 1996
   Google Scholar
• Del Curto MD, Esposito P. Lipid microparticles by cryogenic micronization. US2004091522; 2004
   Google Scholar
• Mumper RJ, Jay M. Microemulsion as precursor to solid nanoparticles. US7153525; 2001
   Google Scholar
• Battaglia L, Trotta M, Cavalli R. Method for the preparation of solid micro and nanoparticles. WO2008149215; 2008
   Google Scholar
• Hertault B, Saulnier P, Benoit JP, Lipid nanocapsules, preparation method and use as medicine. WO0164328; 2001
   Google Scholar
• Shekunov B, Chattopadhyay P, Seitzinger J. Method and apparatus for continuous particle production using supercritical fluid. WO2004071634; 2004
   Google Scholar
• Charcosset C, Fessi H. Novel method for preparing solid lipid nanoparticles using a membrane reactor. WO2007000531; 2007
   Google Scholar